We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ketek Controversy Results in Challenge of FDA Clinical Trial Protocols
Ketek Controversy Results in Challenge of FDA Clinical Trial Protocols
September 15, 2006
Concerns over the FDA's handling of sanofi-aventis’ antibiotic Ketek have led a bipartisan group of lawmakers to ask the Government Accountability Office (GAO) to investigate the agency’s use of a type of clinical trial associated with the drug.